Dangers of the
Sun
Introduction
Skin
cancer is the most rapidly increasing form of cancer in the
Skin Cancer
There
are 3 different types of skin cancer: basal cell carcinoma, squamous
cell carcinoma, and malignant melanoma. 3 Basal cell
carcinoma is the most common form of skin cancer. 3 It presents as a
clear spot or small bump that usually occurs on the head, neck, or hand. 3 Squamous cell carcinoma may
start as nodules or as a red, patchy area, which often occurs on the lips,
face, or tops of the ears. 3 Nonmelanoma skin
cancers, especially squamous cell, have been
associated with cumulative sun exposure, while melanomas have been more closely
associated with brief, intense sun exposure or blistering sunburns. 6, 7
Malignant melanoma is the least common skin cancer, but it is also the most
fatal. 3 Risk factors for melanoma includes the following: light skin color,
family history of melanoma, personal history of melanoma, large number of
moles, presence of freckles (indicator of sun sensitivity and sun damage), and
history of severe sunburns in the early stages of life. 3
Ultraviolet
Radiation
The UV radiation spectrum can be divided into three bands: UVA, UVB, and UVC.8 Little UVC radiation reaches the earth because it is filtered out by the ozone layer. 8 UVC does not cause a person to tan; however, it may cause some erythema of the skin. 8 UVB penetrates superficially into the epidermis and is the principal cause of sunburn reactions.4, 7 UVB is the wavelength that is mostly associated with inducing skin cancer. 8 UVB has been reported to be responsible for causing more than 90 percent of basal and squamous cell cancers. 4, 7, 9
In contrast to the effects caused by UVB, UVA is
responsible for causing a slow natural tan to develop. 8 UVA radiation
penetrate more deeply to the dermis of the skin, which can alter the fibers of
the skin. 3 UVA may also contribute to the cancer-causing potential of UVB
radiation. 3 Sunscreen lotions are more
effective in protecting against shorter ultraviolet wavelengths (UVB) than
against longer wavelengths (UVA). 10
Sunscreens
Sunscreens contain active chemical ingredients that provide protection from the sun through absorption, reflection, and scattering of UV radiation.4 They are usually divided into two categories: physical and chemical. 4 Physical sunscreens are thick, opaque substances that prevent UV radiation from reaching the skin by scattering the sunlight.4 They contain titanium dioxide, zinc oxide, or talc as their active ingredients. 4, 5, 6 These sunscreens are very effective in blocking both UVA and UVB radiation; however, they are messy and usually cosmetically unappealing. 4, 5, 6
Chemical sunscreens are the most commonly used
and are available in a variety of formulations. 4 They contain one or more of
the UV absorbing chemicals. 4 Some of the most widely used chemical groups that
block UVB radiation are PABA (p-aminobenzoic acid),
PABA esters (padimate O), cinnamates
(cinoxate, ethylhexyl-p-methoxycinnamate),
salicylates (octylsalicylate,
homosalate), and anthranilates
(methyl anthranilate). 4, 11 While
these all block UVB radiation, the chemical group known as benzophenone
(oxybenzone and dioxybenzone)
provides protection against both UVA and UVB. 4
Sun Protection Factor (SPF)
Sunscreens have been assigned Sun Protection Factor (SPF) values by the U.S. Food and Drug Administration (FDA) since 1978.12 SPF is a number that refers to the sunscreen product’s ability to block UVB radiation.3 This number does not show the blockade against ultraviolet UVA radiation. Sunscreen products with SPFs of 2 to 50 are currently available.4 A sunscreen product with a SPF of 15 will protect your skin 15 times longer from UVB than if you did not have sunscreen applied. The exact amount of time will vary from person to person, the altitude, and proximity to the equator.3 SPF 15 will block 95% of the UVB wavelengths. SPF 30 does not work twice as well however, it will provide another 3% of protection.3
The efficacy of a product is related not only to
its SPF but also to its substantivity.8 Substantivity
is the ability of a sunscreen to remain effective under the stress of
prolonged exercise, sweating, and swimming.8 The following three labeling
recommendations have been suggested to help clarify substantivity:
It is recommended that sunscreens be reapplied
after swimming or perspiring. However, reapplication of a sunscreen does
not further the period of protection.4
Recommendations
The
Selection of the
Appropriate Sunscreen Product
The individual’s
skin type is an important factor that must be considered when attempting to
choose a sunscreen with the appropriate SPF. 4 In general, very fair-skinned
individuals or those with previously sun-damaged skin may benefit from high SPF
products. 4 None of the available sunscreen products are recommended by the FDA
for use on children under six months of age.8 In addition, products with an SPF
of four or less are not recommended for use on children under two years of age
because they will not provide adequate sun exposure protection.8
Sunscreen Application
Sunscreen should be applied 20 to 30 minutes before sun exposure so the product has a chance to bond with the skin.3 Products containing PABA and PABA-like chemicals, however, may need to be applied up to two hours in advance of sun exposure in order to achieve their maximal effect.5, 8
Most individuals do not apply enough sunscreen
to achieve adequate protection. The SPF is tested at an applied thickness
of 2mg/cm2.13 To cover the average 1.73m2 adult,
approximately 35ml of sunscreen is required. The teaspoon rule of
applying sunscreen is as follows: Apply slightly more than ½ teaspoon (~3ml) to
each arm, to the face and neck. 13 On each leg, the chest and back, apply
slightly more than a teaspoon (~6ml). 13 Using an adequate amount of sunscreen
(2mg/cm2) provides greater sun protection than using
an inadequate amount of a sunscreen with a higher SPF rating. 13
Topical Toxicology
The
FDA report on the over-the-counter (OTC) sunscreen products suggests that human
skin under the age of six months may have different absorptive characteristics
than that of adults. 2 It also suggests that the biological systems that metabolize
and excrete drugs absorbed through the skin may not be fully developed in these
children. 2 Although it is recognized that chemicals absorbed percutaneously result in higher blood concentrations in
children than in adults, this is probably due to their greater ratio of body
surface area to body weight rather than more absorption through the child’s
skin. 11, 14
The FDA recommends that sunscreens containing aminobenzoic acid should be avoided in children younger than six months of age, even though a review of the oral use of aminobenzoic acid in large doses has shown it to be quite safe, even in young children. 2, 6 To provide an added margin of safety, the FDA also recommends that no sunscreens be used on children during the first six months of life. 2, 4
Sunscreens that contain aminobenzoic
acid and its esters (PABA), cinnamates, and oxybenzone can cause contact dermatitis or photosensitivity
reactions. 4 There have also been reports of allergic contact photodermatitis with aminobenzoic
acid, 8 but allergic sensitivity with PABA-containing sunscreens is uncommon.
14
Aminobenzoic acid
is chemically similar to other drugs that cause photosensitivity reactions in
susceptible individuals including thiazides,
sulfonamides, sulfonylureas, furosemide,
and carbonic anhydrase inhibitors. 8 Cross-reactivity
may also occur with benzocaine and paraphenylenediamine. 14 Individuals who
have had photosensitivity reactions while taking any of these drugs should not
use a sunscreen containing aminobenzoic acid or one
of its derivatives (aminobenzoate, menthyl anthranilate, or padimate A or O). 8 A sunscreen containing oxybenzone or cinoxate should be
recommended for these individuals instead. 8 Miscellaneous compounds, such as
fragrances, lanolin, alcohol, and preservatives may also cause skin and eye
irritation or sensitization. 4
In May 1988, a new nitrosamine known as NPABAO
was found in certain sunscreens containing padimate-O
as the active ingredient. 15 Nitrosamines themselves can be carcinogenic;
however, at this time it is uncertain whether this nitrosamine is present in
sufficient quantities in sunscreens to be of concern. 7, 15
Oral Toxicology
Zinc
oxide, an ingredient often found in physical sunscreens, can cause
gastrointestinal irritation if swallowed. Nausea, vomiting, and diarrhea
may occur primarily due to the zinc. The most common symptoms are nausea
and vomiting. 16
Human overdose data on PABA or its esters are rare. Most toxicology data are derived from animal experimentation or chronic, large dose therapeutic use. Nausea, vomiting, and abdominal cramps as well as metallic taste are often seen with oral therapy. Ingestions of more than 10 grams per day for days have been necessary to induce symptoms other than local gastrointestinal irritation. Symptoms are unlikely with normal childhood exposure, and since PABA sunscreens contain 50% or more ethanol, ethanol toxicity may be the greater risk. 16
Many sunscreen products contain a form of salicylate as their active ingredient. For
example, homomenthyl salicylate
(homosalate) is a sunscreen products. Half of the ingested
dose ofâagent
found in many Coppertone homosalate could be
hydrolyzed in vivo to free salicyclic acid and homomenthol. Theoretically, homosalate-containing
sunscreens ingested in substantial amounts may cause salicylate
poisoning; however, there are no such reported cases of salicylate
intoxication. 16
Conclusion
The risks of sun exposure and its
relationship to skin cancer have been well documented. Regular sunscreen
use seems to help limit these harmful effects. The risks of using
sunscreen products appear to be minimal. Therefore routine sunscreen use
should be recommended in all individuals, especially children, exposed to the
sun.
Teresa Le, PharmD IV
References
1. Satcher, D.
“Skin Cancer”. Centers for Disease Control and Prevention.
National Skin Cancer Prevention Education Program.
1997. [available at www.cdc.gov]
2. Hurwitz S. “The Sun and Sunscreen Protection: Recommendations for Children.”
J Dermatol Surg Oncol 14(6):657-660, 1988.
3. “Don’t Let the Sun Spot You.” Centers for Disease
Control and Prevention. Last reviewed May 2003.
[available at www.cdc.gov]
4. Nicol NH. “What’s New With
Sunscreens? Choices-Choices-Choices.” Pediatr Nurs. 15(4):417-418,
1989.
5. Lewis RM, Fischer RG. “Sunscreen Agents.” Pediatr Nurs. 13(3):200-201,
1987.
6. Council on Scientific Affairs. “Harmful Effects of
Ultraviolet Radiation.” JAMA. 262(3):380-384,
1989.
7. Wiss K. “Lasers, Tissue Expansion, and Sun
Protection in Pediatric Dermatology.” Cutis 45:331-333, 1990.
8. DeSimone II EM. “Sunscreen
and Sunscreen Products.” In the Handbook of Nonprescription Drugs, tenth
edition, Feldman EG, Davidson DE, eds., American Pharmaceutical Association,
Washington, DC. 575-587,1986.
9. Stern RS, Weinstein MC, Baker SG. “Risk Reduction for Nonmelanoma Skin Cancer With
Childhood Sunscreen Use.” Arch Dermatol.
122:537-545, 1986.
10. Weinstock MA. “Sunscreen.”
Current opinion in oncology. 12(2):159-62, 2000 Mar.
11. Lester RS. “Topical
Formulary for the Pediatrician.” Ped Clin of
12. Warshauer DM, Steinbaugh
JR. “Sunlight and Protection of the Skin.” AFP.
27(6):109-115, 1983.
13. Schneider J. “The Teaspoon Rule of Applying Sunscreen.” Archives
of Dermatology. 138(6):838-9, 2002 Jun.
14. Norins AL. “Sunscreens for Children.” JAMA. 255(20):2809, 1986.
15. Pathak MA, Robins P. “A Response to Concerns About Sunscreens: A Report From the Skin Cancer Foundation.”
J Dermatol Surg
Oncol. 15(5):486-487, 1989.
16. Ellenhorn MJ, McGuigan MA, Yokel RA, ed. Topical products. Poisindex
Information System. Micromedex, Inc. Exp.
6/2003.